Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, et al. Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting. Eur Urol. 2015;67(4):771–7.
Article
PubMed
PubMed Central
Google Scholar
Merrick GS, Delatore A, Butler WM, Bennett A, Fiano R, Anderson R, Adamovich E. Transperineal template-guided mapping biopsy identifies pathologic differences between very-low-risk and low-risk prostate cancer: implications for active surveillance. Am J Clin Oncol. 2015;40(1):53–9.
Article
Google Scholar
Chang DT, Challacombe B, Lawrentschuk N. Transperineal biopsy of the prostate--is this the future? Nat Rev Urol. 2013;10(12):690–702.
Article
PubMed
Google Scholar
Mai Z, Yan W, Zhou Y, Zhou Z, Chen J, Xiao Y, Liang Z, Ji Z, Li H. Transperineal template-guided prostate biopsy: 10 years of experience. BJU Int. 2016;117(3):424–9.
Article
CAS
PubMed
Google Scholar
Yan W, Li H, Zhou Y, Huang Z, Rong S, Xia M, Ji Z, Chen J, Jiang Y. Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy. Urol Oncol. 2009;27(5):520–4.
Article
PubMed
Google Scholar
Li H, Yan W, Zhou Y, Ji Z, Chen J. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. Urology. 2007;70(6):1157–61.
Article
PubMed
Google Scholar
Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate. 2013;73(7):778–87.
Article
PubMed
Google Scholar
D’Amico AV, Davis A, Vargas SO, Renshaw AA, Jiroutek M, Richie JP. Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated? Int J Radiat Oncol Biol Phys. 1999;43(3):587–90.
Article
PubMed
Google Scholar
Perera M, Lawrentschuk N, Bolton D, Clouston D. Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens. BJU Int. 2014;113(Suppl 2):29–34.
Article
PubMed
Google Scholar
Richters A, Derks J, Husson O, Van Onna IEW, Fossion LMCL, Kil PJM, Verhoeven RHA, Aarts MJ. Effect of surgical margin status after radical prostatectomy on health-related quality of life and illness perception in patients with prostate cancer. Urol Oncol. 2015;33(1):16.e9–16.e15.
Article
Google Scholar
Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, et al. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol. 2017;18(2):181–91.
Article
CAS
PubMed
Google Scholar
Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.
Article
PubMed
PubMed Central
Google Scholar
Ahmed HU, Dickinson L, Charman S, Weir S, McCartan N, Hindley RG, Freeman A, Kirkham AP, Sahu M, Scott R, et al. Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study. Eur Urol. 2015;68(6):927–36.
Article
PubMed
Google Scholar
Singh PB, Anele C, Dalton E, Barbouti O, Stevens D, Gurung P, Arya M, Jameson C, Freeman A, Emberton M, et al. Prostate Cancer tumour features on template prostate-mapping biopsies: implications for focal therapy. Eur Urol. 2014;66(1):12–9.
Article
PubMed
PubMed Central
Google Scholar
Sivaraman A, Barret E. Focal therapy for prostate cancer: an “à la carte” approach. Eur Urol. 2016;69(6):973–5.
Article
PubMed
Google Scholar
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer. 1997;20(5):680–8.
Article
Google Scholar
Bittner N, Merrick GS, Butler WM, Bennett A, Galbreath RW. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol. 2013;190(2):509–14.
Article
PubMed
Google Scholar
Bott SR, Young MP, Kellett MJ, Parkinson MC. Contributors to the UCL Hospitals’ Trust Radical Prostatectomy Database. Anterior prostate cancer: is it more difficult to diagnose? BJU Int. 2002;89(9):886–9.
Article
CAS
PubMed
Google Scholar
Furuno T, Demura T, Kaneta T, Gotoda H, Muraoka S, Sato T, Nagamori S, Shinohara N, Koyanagi T. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate. 2004;58(1):76–81.
Article
PubMed
Google Scholar
Kido M, Hitosugi M, Ishii K, Kamimura S, Joh K. Latent prostate cancer in Japanese men who die unnatural deaths: a forensic autopsy study. Prostate. 2015;75(9):917–22.
Article
PubMed
Google Scholar
Huo AS, Hossack T, Symons JL, PeBenito R, Delprado WJ, Brenner P, Stricker PD. Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens. J Urol. 2012;187(6):2044–9.
Article
PubMed
Google Scholar
Zhang Q, Wang W, Zhang B, Shi J, Fu Y, Li D, Guo S, Zhang S, Huang H, Jiang X, et al. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China. Int Urol Nephrol. 2017;49(3):439–48.
Article
PubMed
Google Scholar
Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol. 2015;67(4):787–94.
Article
PubMed
Google Scholar
Gordetsky J, Rais-Bahrami S, Epstein JI. Pathological findings in multiparametric magnetic resonance imaging/ultrasound fusion-guided biopsy: relation to prostate cancer focal therapy. Urology. 2017;105:18–23.
Article
PubMed
Google Scholar
van de Ven WJ, Venderink W, Sedelaar JP, Veltman J, Barentsz JO, Futterer JJ, Cornel EB, Huisman HJ. MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience. Int Urol Nephrol. 2016;48(7):1037–45.
Article
PubMed
PubMed Central
Google Scholar